A drug is like a special toy that helps people feel better when they're sick, but figuring out which toy works best can be tricky, especially with AI, which acts like a super-smart robot helping scientists find new toys.
In AI-driven drug discovery, intellectual property (IP) challenges come up because the robot might find a great new toy that no one knew about before. But who gets to say it's their toy?
Who owns the toy?
If a company uses an AI robot, and the robot finds a new drug, there’s a question: does the company own the toy, or does the robot, or maybe even the scientists who trained the robot, get to keep it? It's like if your friend used a super-smart robot to find a hidden treasure in your backyard. Would you get to keep it, or would your friend?
What if the robot copied someone else’s toy?
Sometimes, the AI robot might copy ideas from other people's toys, like using parts of another person’s puzzle to make something new. That can cause problems because the original inventor might feel their idea was taken.
It's all about figuring out who gets to use the toy first and who gets to claim it as their own.
Examples
- A company uses AI to find a new drug, but another company claims they discovered it first.
- AI creates a molecule that cures a disease, but no one knows who owns the patent.
- Two labs use different AIs to discover the same drug at almost the same time.
Ask a question
See also
- How is AI-generated content created and what are its applications?
- How do AI deepfakes trick people so easily?
- How does AI influence search engines and present information overviews?
- How do AI models create realistic video from text prompts?
- How do AI language models generate text like humans?